Gene: UBQLN1
Official Full Name: ubiquilin 1provided by HGNC
Gene Summary: This gene encodes an ubiquitin-like protein (ubiquilin) that shares a high degree of similarity with related products in yeast, rat and frog. Ubiquilins contain an N-terminal ubiquitin-like domain and a C-terminal ubiquitin-associated domain. They physically associate with both proteasomes and ubiquitin ligases, and thus are thought to functionally link the ubiquitination machinery to the proteasome to affect in vivo protein degradation. This ubiquilin has also been shown to modulate accumulation of presenilin proteins, and it is found in lesions associated with Alzheimer's and Parkinson's disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00197 | UBQLN1 gRNA1-gRNA2 KO plasmid | UBQLN1 | $850 | |||
KO00365 | UBQLN1 Knockout cell line(Flp-In-TRex U2OS) | Human | UBQLN1 | 1:3~1:5 | Negative | Online Inquiry |
KO00631 | UBQLN1 Knockout cell line (HEK293) | Human | UBQLN1 | 1:3~1:6 | Negative | Online Inquiry |
KO02743 | UBQLN1 Knockout cell line (HeLa) | Human | UBQLN1 | 1:3~1:6 | Negative | Online Inquiry |
KO02744 | UBQLN1 Knockout cell line (HCT 116) | Human | UBQLN1 | 1:2~1:4 | Negative | Online Inquiry |
KO02745 | UBQLN1 Knockout cell line (A549) | Human | UBQLN1 | 1:3~1:4 | Negative | Online Inquiry |
UBQLN1 Gene Knockout Cell Lines are genetically engineered cell lines in which the UBQLN1 gene has been selectively inactivated or disrupted. This product is designed to facilitate the investigation of the gene's function and its role in cellular processes such as protein degradation, cellular stress responses, and neurodegenerative diseases. By employing CRISPR-Cas9 technology or similar gene-editing methods, these knockout cell lines offer researchers a reliable system for studying the phenotypic consequences of UBQLN1 deficiency in a controlled environment.
The primary function of UBQLN1 is to regulate proteostasis by directing misfolded or damaged proteins to the proteasome for degradation. This gene is implicated in various pathologies, making its study critical in uncovering the mechanisms of disease, particularly in neurodegeneration, where the accumulation of damaged proteins is a hallmark. By utilizing UBQLN1 knockout cell lines, researchers can elucidate the pathways affected by UBQLN1 loss, enabling a comprehensive understanding of its involvement in disease mechanisms and potential therapeutic targets.
The scientific importance of these cell lines is underscored by their utility in both foundational research and clinical applications. They can serve as valuable models for drug screening, the validation of therapeutic interventions, and the development of new biomarkers for disease states. Additionally, these models are essential for studying the implications of UBQLN1 in age-related conditions and neurodegenerative disorders, thereby providing insights that can drive innovation in treatment approaches.
Compared to alternative models, UBQLN1 Gene Knockout Cell Lines stand out due to their specificity, reliability, and the ability to replicate physiological conditions found in human tissues. With the breakthrough of gene editing techniques, they offer precise control over genetic modifications, ensuring that researchers can obtain high-fidelity data that is crucial for the advancement of scientific knowledge.
For researchers, clinicians, and pharmaceutical developers alike, the value of UBQLN1 Gene Knockout Cell Lines cannot be overstated. They provide a sophisticated tool for probing cellular mechanisms and for advancing translational medicine. Our company specializes in producing high-quality, validated gene knockout models, backed by extensive expertise in genetic engineering and cell biology, ensuring that you receive dependable and innovative solutions to enhance your research and clinical endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.